Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
To the Editor: When addressing changes in symptom severity in patients with psychiatric disorders, it is important to consider psychosocial stressors before jumping to pharmaceutical interventions. Here, 2 cases are presented to illustrate this point.
Case 1. Ms A is a 54-year-old woman with a DSM-5 diagnosis of recurrent major depressive disorder in remission on fluoxetine 20 mg daily.
Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
Please sign in or purchase this PDF for $40.00.